AGA Backs Fecal Microbiota-Based Therapies for Recurrent C. Diff

(MedPage Today) -- The American Gastroenterological Association (AGA) endorsed the use of fecal microbiota-based therapies for recurrent Clostridioides difficile infections (CDIs) in new guideline recommendations, but advised against such therapies...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Gastroenterology